Tag Archives: ANIP

Top 5 Heal Care Stocks To Watch For 2019

The main message is still intact. But energy prices decided to back down a little because there is still some production overhang in the market. However, Resolute Energy (REN) still has some of the best wells in the business and now has sold the high cost operations. Stockholders can be prepared for some of the lowest costs in the business from some of the larger wells in the Permian. That happy combination should be robust enough to provide generous returns in many of the forecast future commodity price scenarios. The common stock, which is up a lot, still has a lot more appreciation left in the future. The increasing drilling activity means that the fun has just begin despite some already impressive (and industry leading) returns.

Top 5 Heal Care Stocks To Watch For 2019: St. Jude Medical, Inc.(STJ)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Deutsche Bank upgraded shares of St. James’s Place (LON:STJ) to a buy rating in a research report released on Thursday. They currently have GBX 1,430 ($19.19) target price on the stock, up from their prior target price of GBX 1,310 ($17.58).

  • [By Ethan Ryder]

    Press coverage about St Jude Medical (NYSE:STJ) has trended positive on Saturday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. St Jude Medical earned a news sentiment score of 0.26 on Accern’s scale. Accern also gave news coverage about the medical technology company an impact score of 47.0517782357178 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

  • [By Stephan Byrd]

    Media headlines about St Jude Medical (NYSE:STJ) have been trending positive recently, according to Accern. Accern identifies positive and negative press coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. St Jude Medical earned a coverage optimism score of 0.26 on Accern’s scale. Accern also gave media coverage about the medical technology company an impact score of 46.7237518599623 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

Top 5 Heal Care Stocks To Watch For 2019: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) have been trending somewhat negative recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ANI Pharmaceuticals Inc Common Stock earned a media sentiment score of -0.08 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 48.3270217581665 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Max Byerly]

    Virginia Retirement Systems ET AL reduced its position in ANI Pharmaceuticals Inc (NASDAQ:ANIP) by 59.2% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 13,100 shares of the specialty pharmaceutical company’s stock after selling 19,000 shares during the period. Virginia Retirement Systems ET AL’s holdings in ANI Pharmaceuticals were worth $590,000 at the end of the most recent reporting period.

  • [By Motley Fool Transcribing]

    ANI Pharmaceuticals (NASDAQ:ANIP) Q4 2018 Earnings Conference CallFeb. 27, 2019 10:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Max Byerly]

    Mallinckrodt (NYSE: MNK) and ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Top 5 Heal Care Stocks To Watch For 2019: Aurinia Pharmaceuticals Inc(AUPH)

Advisors’ Opinion:

  • [By Keith Speights]

    That statement comes to mind when I think about Aurinia Pharmaceuticals (NASDAQ:AUPH). The potential for the clinical-stage biotech appears to be so great that getting greedy with the stock is tempting. 

  • [By Logan Wallace]

    Isotechnika Pharma Inc. (NASDAQ:AUPH) (TSE:AUP) shares rose 6.7% during trading on Friday . The stock traded as high as $5.68 and last traded at $5.59. Approximately 54,590 shares traded hands during mid-day trading, a decline of 87% from the average daily volume of 429,596 shares. The stock had previously closed at $5.24.

  • [By Brian Orelli]

    Shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) jumped 11% in May, according to data provided by S&P Global Market Intelligence, after the biotech said it plans to test voclosporin, its only drug candidate, for additional diseases.

  • [By Cory Renauer]

    Shares of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), a biotechnology company developing an experimental new lupus therapy, rose 16.8% in September, according to data from S&P Global Market Intelligence. Analyst attention following an important step forward for the company’s lead candidate pushed the stock higher.

  • [By Ethan Ryder]

    Aurinia Pharmaceuticals (TSE:AUP) (NASDAQ:AUPH) issued its quarterly earnings data on Thursday. The company reported C($0.25) earnings per share for the quarter, missing analysts’ consensus estimates of C($0.21) by C($0.04), reports. The firm had revenue of C$0.04 million during the quarter, compared to analyst estimates of C$0.07 million. Aurinia Pharmaceuticals had a negative return on equity of 30.41% and a negative net margin of 45,241.38%.

Top 5 Heal Care Stocks To Watch For 2019: Clean Diesel Technologies Inc.(CDTI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Shares of CDTi Advanced Materials Inc (NASDAQ:CDTI) hit a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $0.33 and last traded at $0.36, with a volume of 500 shares trading hands. The stock had previously closed at $0.36.

  • [By Stephan Byrd]

    Here are some of the media stories that may have impacted Accern Sentiment’s analysis:

    Get Molecular Templates alerts:

    Trading Center: Watching the Levels for Molecular Templates, Inc. (:MTEM): Move of 0.02 Since the Open (stocknewscaller.com) Molecular Templates (MTEM) Announces Clinical Data at 2018 ASCO Meeting (streetinsider.com) Gallbladder Cancer Treatment Sales Market Size by Players, Regions, Type, Application and Forecast to 2025 (exclusivereportage.com) ATR in spotlight EnSync, Inc. (NYSE:ESNC), CDTi Advanced Materials, Inc. (NASDAQ:CDTI), Molecular Templates, Inc … (stocksnewspoint.com)

    MTEM has been the subject of several research analyst reports. ValuEngine lowered shares of Molecular Templates from a “hold” rating to a “sell” rating in a research report on Thursday, March 1st. Zacks Investment Research raised shares of Molecular Templates from a “sell” rating to a “hold” rating in a research report on Thursday, June 7th. Four analysts have rated the stock with a hold rating and one has given a buy rating to the stock. The company has a consensus rating of “Hold” and an average price target of $5.20.

Top 5 Heal Care Stocks To Watch For 2019: Turkcell Iletisim Hizmetleri AS(TKC)

Advisors’ Opinion:

  • [By Lee Jackson]

    Turkcell Iletisim Hizmetleri A.S. (NASDAQ: TKC) was started with an overweight rating at J.P. Morgan. The 52-week trading range for the company’s shares has been $6.33 to $11.29. The consensus price target is $10.94. The shares ended trading on Monday at $6.58.

  • [By Ethan Ryder]

    Turkcell (NYSE:TKC) shares reached a new 52-week high and low during trading on Friday . The stock traded as low as $7.59 and last traded at $7.74, with a volume of 559325 shares traded. The stock had previously closed at $8.02.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Fluor Corporation (NYSE: FLR) fell 13.4 percent to $51.10 in pre-market trading after the company reported downbeat earnings for its first quarter and lowered its profit outlook for the year.
    Integrated Media Technology Limited (NASDAQ: IMTE) fell 9.8 percent to $28.97 in pre-market trading after surging 46.29 percent on Thursday.
    Gogo Inc. (NASDAQ: GOGO) shares fell 8.2 percent to $8.81 in pre-market trading after the company reported Q1 results and disclosed that it is withdrawing its FY18 outlook for adjusted EBITDA, airborne cash capex, airborne equipment inventory purchases and free cash flow.
    Sharing Economy International Inc. (NASDAQ: SEII) shares fell 7.5 percent to $3.98 in pre-market trading after climbing 22.16 percent on Thursday.
    Arista Networks, Inc. (NYSE: ANET) fell 7.4 percent to $248.00 in pre-market trading following first-quarter earnings.
    Web.com Group, Inc. (NASDAQ: WEB) fell 6.7 percent to $18.00 in pre-market trading after reporting Q1 results.
    Varex Imaging Corporation (NASDAQ: VREX) fell 5.2 percent to $34 in pre-market trading after reporting Q2 results.
    Turkcell Iletisim Hizmetleri A.S. (NYSE: TKC) shares fell 5.2 percent to $7.60 in pre-market trading after dropping 3.02 percent on Thursday.
    AMN Healthcare Services, Inc (NYSE: AMN) shares fell 4.7 percent to $61.70 in pre-market trading following Q1 earnings.
    HSBC Holdings plc (NYSE: HSEA) fell 4.6 percent to $25.15 in pre-market trading after reporting Q1 results.
    Stratasys Ltd. (NASDAQ: SSYS) shares fell 4 percent to $16.66 in pre-market trading after dropping 2.86 percent on Thursday.
    Melco Resorts & Entertainment Limited (NASDAQ: MLCO) fell 4 percent to $30.65 in pre-market trading.
    Century Aluminum Co (NASDAQ: CENX) fell 4 percent to $15.76 in pre-market trading following Q1 results.
    HSBC Holdings plc (NYSE: HSBC) shares fell 3.5 percent to $48.10 in pre-market tr

  • [By Rich Smith]

    Turkish telco Turkcell Iletisim Hizmetleri (NYSE:TKC) closed up 11.6% on Thursday after the country’s central bank announced a big boost to interest rates — 24%, or 6.25 percentage points more than previously — boosting the Turkish lira’s value against the U.S. dollar for the third straight day.

  • [By Dan Caplinger]

    The stock market lost ground on Monday, although the declines in some major benchmarks were more extreme than others. A budding financial crisis in Turkey once again captured the attention of investors, as the threat of rising tariffs and escalating diplomatic tension could drive a wedge through the North Atlantic Treaty Organization at a critical time for the geopolitical environment in the region. The repercussions of recent events involving Turkey echoed around the world, and some companies felt the tremors more sharply than others. First Majestic Silver (NYSE:AG), Turkcell Iletisim Hizmetleri (NYSE:TKC), and Transocean (NYSE:RIG) were among the worst performers on the day. Here’s why they did so poorly.

Top 10 Heal Care Stocks To Watch Right Now

Royal Bank of Canada lowered shares of INMARSAT PLC/ADR (OTCMKTS:IMASY) from an outperform rating to a sector perform rating in a research note issued to investors on Tuesday morning, The Fly reports.

Other analysts also recently issued reports about the company. Zacks Investment Research raised INMARSAT PLC/ADR from a sell rating to a hold rating in a research report on Tuesday, August 14th. ValuEngine raised INMARSAT PLC/ADR from a sell rating to a hold rating in a research report on Tuesday, June 26th. Eight analysts have rated the stock with a hold rating, INMARSAT PLC/ADR currently has an average rating of Hold and a consensus target price of $5.75.

Get INMARSAT PLC/ADR alerts:

OTCMKTS:IMASY opened at $6.67 on Tuesday. The company has a quick ratio of 0.95, a current ratio of 0.99 and a debt-to-equity ratio of 1.94. INMARSAT PLC/ADR has a 1 year low of $4.70 and a 1 year high of $9.03.

Top 10 Heal Care Stocks To Watch Right Now: Marathon Oil Corporation(MRO)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Melrose Industries (LON:MRO) had its price target upped by Numis Securities from GBX 250 ($3.39) to GBX 280 ($3.80) in a research report report published on Monday morning. They currently have a buy rating on the stock.

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) delivered strong operational and financial results through the third quarter of last year, which had the company on track to end 2018 on a high note. Investors will find out whether that’s the case when the company reports its fourth-quarter results. That’s one of several things they should keep their eye on when reviewing that report.

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) also has cashed in on the improvement in oil prices. Shares of the U.S. oil company are up more than 80% over the past year — making it one of the best-performing oil stocks of 2018 — due to the impact higher oil prices are having on its cash flow. Like EOG, Marathon Oil set its budget to run on $50 oil, which has it on pace to produce $500 million in free cash at $60 a barrel and even more at current prices.

  • [By Matthew DiLallo]

    That ability to organically discover new shale plays has saved it a ton of money. The company was able to quietly gobble up 50,000 acres in Oklahoma over a four-year period for just $750 an acre. Contrast that with rivals Devon Energy (NYSE:DVN) and Marathon Oil (NYSE:MRO). Devon spent $1.9 billion to buy Felix Energy in late 2015 for the company’s 80,000 acres in Oklahoma, paying a whopping $23,750 an acre. Meanwhile, Marathon paid $888 million for PayRock Energy and its 61,000 acres in the state, which amounted to roughly $14,500 an acre. EOG’s deep knowledge of shale helps it know where to look so it can lock up land for next to nothing before rivals even know what’s there.

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO) put the wraps on a strong year by delivering solid fourth-quarter results, which came in slightly ahead of expectations. With that, the company exceeded its initial growth projection for the year while sticking to its budget, and was thus able to generate and return lots of cash to shareholders. The company expects more of the same in 2019 as its drilling machine aims to continue printing money.

Top 10 Heal Care Stocks To Watch Right Now: Natural Gas(NG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    National Grid (LON:NG)‘s stock had its “overweight” rating reiterated by research analysts at Morgan Stanley in a note issued to investors on Monday.

  • [By Money Morning Staff Reports]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400.

  • [By Stephan Byrd]

    Novagold Resources (NASDAQ:NG) was upgraded by equities research analysts at BidaskClub from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday.

  • [By Money Morning News Team]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last six months, the volume of short bets on the stock declined 32.75%, from 19.05 million shares to 12.81 million.

  • [By Max Byerly]

    NovaGold Resources Inc. (NYSEAMERICAN:NG) (TSE:NG) VP David A. Ottewell sold 60,309 shares of the firm’s stock in a transaction on Wednesday, September 12th. The stock was sold at an average price of $3.73, for a total value of $224,952.57. Following the transaction, the vice president now owns 645,385 shares in the company, valued at $2,407,286.05. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Top 10 Heal Care Stocks To Watch Right Now: priceline.com Incorporated(PCLN)

Advisors’ Opinion:

  • [By ]

    Will Target (NYSE: TGT) get its mojo back, or will shoppers flock to Walmart (NYSE: WMT)? Which travel agent books more snow ski trips this season, Expedia (Nasdaq: EXPE) or Priceline (Nasdaq: PCLN)? Which video game console emerges on top, Microsoft’s Xbox or Nintendo’s Switch?

  • [By Money Morning Staff Reports]

    Through Tom’s various strategies, followers had the chance to pocket gains of 195.36% in 16 days on Priceline Group Inc. (Nasdaq: PCLN), 193.39% in 16 days on SPDR Gold Trust (ETF) (NYSE Arca: GLD), 100% in eight days on International Business Machines Corp. (NYSE: IBM), and even 248.42% in 17 days on SPDR Dow Jones Industrial Average ETF (NYSE Arca: DIA).

  • [By Jack Delaney]

    For example, owning just one share of The Priceline Group Inc. (Nasdaq: PCLN) would cost $1,921.53. But some of these stocks aren’t quite as “expensive” as they seem…

Top 10 Heal Care Stocks To Watch Right Now: W&T Offshore Inc.(WTI)

Advisors’ Opinion:

  • [By Stephan Byrd]

    W&T Offshore (NYSE:WTI) last issued its quarterly earnings data on Wednesday, May 2nd. The oil and gas company reported $0.19 EPS for the quarter, hitting analysts’ consensus estimates of $0.19. The firm had revenue of $134.20 million during the quarter, compared to analyst estimates of $137.80 million. W&T Offshore had a negative return on equity of 15.43% and a net margin of 16.71%. The company’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.16 EPS. equities analysts forecast that W&T Offshore, Inc. will post 0.66 earnings per share for the current year.

  • [By Dan Caplinger]

    The stock market had a mixed day on Wednesday, with gains for the Dow Jones Industrial Average coming largely at the expense of the tech-heavy Nasdaq Composite, as well as smaller-company stocks. Investors were encouraged by solid economic data showing strength in the housing market, and strength in the financial sector was especially helpful for the Dow. Nervousness about potential regulation of high-flying tech stocks dampened market sentiment to some extent, but a few individual stocks posted sizable gains. GW Pharmaceuticals (NASDAQ:GWPH), Baidu (NASDAQ:BIDU), and W&T Offshore (NYSE:WTI) were among the best performers on the day. Here’s why they did so well.

  • [By Joseph Griffin]

    W&T Offshore (NYSE:WTI) was upgraded by stock analysts at ValuEngine from a “sell” rating to a “hold” rating in a research report issued on Thursday.

  • [By Stephan Byrd]

    W&T Offshore, Inc. (NYSE:WTI) gapped down prior to trading on Thursday . The stock had previously closed at $5.69, but opened at $5.94. W&T Offshore shares last traded at $5.76, with a volume of 103016 shares trading hands.

  • [By Stephan Byrd]

    W&T Offshore, Inc. (NYSE:WTI)’s share price fell 6.8% during trading on Tuesday . The stock traded as low as $9.15 and last traded at $9.17. 3,599,325 shares traded hands during trading, an increase of 9% from the average session volume of 3,308,699 shares. The stock had previously closed at $9.84.

Top 10 Heal Care Stocks To Watch Right Now: Marcus Corporation (MCS)

Advisors’ Opinion:

  • [By Max Byerly]

    Here are some of the news headlines that may have effected Accern Sentiment’s rankings:

    Get Marcus alerts:

    Bill Barnwell puts Marcus Mariota on his “Now or Never” list (msn.com) Marcus Lemonis: This is the first step to starting a successful business (cnbc.com) Marcus Mariota progressing in new offense (msn.com) Marcus Corp (MCS) Receives Consensus Rating of “Hold” from Analysts (americanbankingnews.com) Goldman’s Marcus is coming to the UK (businessinsider.com)

    A number of research firms have commented on MCS. B. Riley cut shares of Marcus from a “buy” rating to a “neutral” rating and cut their price target for the stock from $42.50 to $41.00 in a research note on Wednesday, August 15th. ValuEngine raised shares of Marcus from a “hold” rating to a “buy” rating in a research note on Thursday, July 26th. Barrington Research reaffirmed a “buy” rating and issued a $36.00 price objective on shares of Marcus in a research note on Thursday, July 26th. Finally, Zacks Investment Research cut shares of Marcus from a “hold” rating to a “sell” rating in a research note on Wednesday, July 25th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the company’s stock. Marcus presently has an average rating of “Hold” and a consensus target price of $35.25.

  • [By Motley Fool Transcribers]

    Marcus Corp  (NYSE:MCS)Q4 2018 Earnings Conference CallFeb. 21, 2019, 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Stephan Byrd]

    McCarthy & Stone (LON:MCS) had its price target lowered by equities researchers at Deutsche Bank from GBX 189 ($2.52) to GBX 165 ($2.20) in a research report issued to clients and investors on Wednesday. The firm currently has a “buy” rating on the stock. Deutsche Bank’s target price would indicate a potential upside of 52.50% from the company’s current price.

  • [By Ethan Ryder]

    AMC Entertainment (NYSE: AMC) and Marcus (NYSE:MCS) are both consumer discretionary companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, analyst recommendations and risk.

  • [By Max Byerly]

    In other news, VP Thomas F. Kissinger sold 10,000 shares of Marcus stock in a transaction dated Wednesday, March 7th. The stock was sold at an average price of $29.12, for a total value of $291,200.00. Following the transaction, the vice president now owns 81,664 shares in the company, valued at $2,378,055.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Diane M. Gershowitz sold 12,750 shares of the firm’s stock in a transaction dated Friday, April 6th. The stock was sold at an average price of $30.86, for a total value of $393,465.00. Following the completion of the sale, the director now directly owns 7,482 shares in the company, valued at $230,894.52. The disclosure for this sale can be found here. Insiders have sold 44,250 shares of company stock valued at $1,343,255 in the last three months. 32.88% of the stock is owned by corporate insiders.

    ILLEGAL ACTIVITY WARNING: “Barrington Research Brokers Lower Earnings Estimates for Marcus Co. (MCS)” was originally published by Ticker Report and is owned by of Ticker Report. If you are viewing this piece of content on another site, it was illegally stolen and republished in violation of United States and international trademark & copyright legislation. The original version of this piece of content can be read at www.tickerreport.com/banking-finance/3367299/barrington-research-brokers-lower-earnings-estimates-for-marcus-co-mcs.html.

    Marcus Company Profile

Top 10 Heal Care Stocks To Watch Right Now: iShares MSCI Japan (EWJ)

Advisors’ Opinion:

  • [By Shane Hupp]

    Traders sold shares of iShares MSCI Japan ETF (NYSEARCA:EWJ) on strength during trading on Tuesday. $26.39 million flowed into the stock on the tick-up and $78.06 million flowed out of the stock on the tick-down, for a money net flow of $51.67 million out of the stock. Of all equities tracked, iShares MSCI Japan ETF had the 22nd highest net out-flow for the day. iShares MSCI Japan ETF traded up $0.12 for the day and closed at $56.92

  • [By Zacks]

    iShares MSCI Japan ETF (NYSE: EWJ)

    This fund is suitable for investors looking for broad-based exposure to the Japanese economy. It seeks to invest in large-cap companies.

  • [By Logan Wallace]

    Cookson Peirce & Co. Inc. acquired a new stake in iShares MSCI Japan ETF (NYSEARCA:EWJ) during the first quarter, according to its most recent 13F filing with the SEC. The fund acquired 5,090 shares of the exchange traded fund’s stock, valued at approximately $309,000.

  • [By Stephan Byrd]

    Stephens Inc. AR bought a new stake in shares of iShares MSCI Japan ETF (NYSEARCA:EWJ) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 9,591 shares of the exchange traded fund’s stock, valued at approximately $555,000.

Top 10 Heal Care Stocks To Watch Right Now: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Headlines about ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) have been trending somewhat negative recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ANI Pharmaceuticals Inc Common Stock earned a media sentiment score of -0.08 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 48.3270217581665 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Max Byerly]

    Mallinckrodt (NYSE: MNK) and ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Top 10 Heal Care Stocks To Watch Right Now: Daily Journal Corp. (S.C.)(DJCO)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Daily Journal (NASDAQ:DJCO) from a buy rating to a hold rating in a research report released on Tuesday.

    Separately, TheStreet raised shares of Daily Journal from a c- rating to a b rating in a report on Monday, February 12th.

Top 10 Heal Care Stocks To Watch Right Now: iShares 20+ Year Treasury Bond (TLT)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of Nationwide Fund Advisors’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Nationwide+Fund+Advisors

    These are the top 5 holdings of Nationwide Fund AdvisorsiShares Core MSCI Emerging Markets (IEMG) – 4,698,924 shares, 74.25% of the total portfolio. Shares added by 119.53%iShares 20+ Year Treasury Bond ETF (TLT) – 536,574 shares, 17.7% of the total portfolio. Shares added by 79.94%iShares iBoxx $ High Yield Corporate Bond (HYG) – 347,518 shares, 8.05% of the total portfolio. Shares reduced by 20.57%

  • [By Shane Hupp]

    iShares Barclays 20+ Yr Treas.Bond (NASDAQ:TLT) announced a monthly dividend on Monday, July 2nd, Wall Street Journal reports. Stockholders of record on Tuesday, July 3rd will be given a dividend of 0.2749 per share by the exchange traded fund on Monday, July 9th. This represents a $3.30 annualized dividend and a dividend yield of 2.72%. The ex-dividend date of this dividend is Monday, July 2nd.

  • [By Logan Wallace]

    TRADEMARK VIOLATION WARNING: “Theralase Technologies (TLT) Hits New 52-Week High at $0.50” was published by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another domain, it was copied illegally and reposted in violation of US & international copyright & trademark legislation. The legal version of this report can be accessed at www.tickerreport.com/banking-finance/4158304/theralase-technologies-tlt-hits-new-52-week-high-at-0-50.html.

Top 10 Heal Care Stocks To Watch Right Now: Cathay General Bancorp(CATY)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Cathay General Bancorp (NASDAQ:CATY) – Equities research analysts at Piper Jaffray Companies reduced their Q4 2018 EPS estimates for shares of Cathay General Bancorp in a research report issued on Wednesday, July 18th. Piper Jaffray Companies analyst M. Clark now anticipates that the bank will post earnings of $0.76 per share for the quarter, down from their prior estimate of $0.79. Piper Jaffray Companies also issued estimates for Cathay General Bancorp’s Q3 2019 earnings at $0.89 EPS, Q4 2019 earnings at $0.90 EPS, FY2019 earnings at $3.50 EPS, Q1 2020 earnings at $0.89 EPS, Q2 2020 earnings at $0.89 EPS and FY2020 earnings at $3.65 EPS.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Cathay General Bancorp (CATY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Aurora Investment Counsel bought a new position in shares of Cathay General Bancorp (NASDAQ:CATY) in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 43,515 shares of the bank’s stock, valued at approximately $1,803,000. Aurora Investment Counsel owned 0.05% of Cathay General Bancorp as of its most recent SEC filing.

Hot Undervalued Stocks To Watch Right Now

JM Financial’s research report on GTPL Hathway

GTPL reported standalone 4Q and FY18 results, and consolidated FY18 results on Friday. Its consol. revenue of INR 10.9bn [+20% yoy] was 2.8% below our forecast, but excluding activation, adjusted revenue of INR 10.0bn was 2.3% lower. Further, FY18 EBITDA of INR 2.92bn [+42%] was 4.6% lower, but adj. EBITDA of INR 1.98bn [+51%] was merely 2.5% below our forecast. Reported FY18 PAT was INR 611mn, but adjusting for exceptional item [42mn expense], and prior period taxes [50mn estimate], GTPL’s normalised PAT of INR 703mn was up 75% yoy, but came in c.11% lower. Further, despite marginally lower EBITDA and higher capex [INR 2.87bn vs. 2.75bn forecast], GTPL’s net debt of INR 1.93bn was below our estimate [2.33bn], thanks to lower receivables and higher payables. GTPL’s board has recommended DPS of INR 1.0 for FY18 (18.4% pay out; 22% gross), which we find disappointing, given the company’s under leveraged balance sheet—0.66x ND/EBITDA ratio. GTPL remains the best run and the most undervalued video business among listed MSOs, having exposure to a secular home-broadband-growth opportunity.

Hot Undervalued Stocks To Watch Right Now: Gladstone Land Corporation(LAND)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Gladstone Land (LAND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Gladstone Land (LAND)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Landsec (LON:LAND) announced a dividend on Tuesday, May 15th, Upcoming.Co.Uk reports. Investors of record on Thursday, June 21st will be given a dividend of GBX 14.65 ($0.20) per share on Friday, July 27th. This represents a yield of 1.54%. The ex-dividend date of this dividend is Thursday, June 21st. This is an increase from Landsec’s previous dividend of $9.85. The official announcement can be viewed at this link.

  • [By Max Byerly]

    Strs Ohio increased its holdings in shares of Gladstone Land Corp (NASDAQ:LAND) by 47.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 22,299 shares of the real estate investment trust’s stock after purchasing an additional 7,216 shares during the quarter. Strs Ohio owned approximately 0.14% of Gladstone Land worth $282,000 at the end of the most recent quarter.

Hot Undervalued Stocks To Watch Right Now: Core Laboratories N.V.(CLB)

Advisors’ Opinion:

  • [By Stephan Byrd]

    TRADEMARK VIOLATION NOTICE: “Core Laboratories (CLB) Position Increased by Arizona State Retirement System” was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another site, it was stolen and republished in violation of U.S. & international trademark and copyright law. The legal version of this piece can be viewed at www.tickerreport.com/banking-finance/4153048/core-laboratories-clb-position-increased-by-arizona-state-retirement-system.html.

  • [By Steve Symington]

    But several individual companies bucked the indexes’ trend. Read on to learn why MiMedx Group (NASDAQ:MDXG), Core Laboratories (NYSE:CLB), and Nordstrom (NYSE:JWN) trailed the broader market today.

  • [By Stephan Byrd]

    Core Laboratories (NYSE: CLB) and North American Construction Group (NYSE:NOA) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations and earnings.

  • [By Shane Hupp]

    Here are some of the news stories that may have impacted Accern Sentiment’s analysis:

    Get Core Laboratories alerts:

    Cypress Energy Partners (CELP) vs. Core Laboratories (CLB) Head-To-Head Contrast (americanbankingnews.com) Core Laboratories (CLB) Receives Average Rating of “Hold” from Brokerages (americanbankingnews.com) Core Laboratories (CLB) Stock Rating Upgraded by ValuEngine (americanbankingnews.com) Core Laboratories NV (CLB) Reached 12-Month High on May, 16 at $126.33 (usindexlive.com) Increase in Demand for POC Testing to Boost the Fecal Occult Testing Market| Technavio (oaoa.com)

    Core Laboratories opened at $127.31 on Monday, Marketbeat reports. Core Laboratories has a 52-week low of $86.55 and a 52-week high of $130.34. The firm has a market cap of $5.63 billion, a PE ratio of 63.66 and a beta of 1.38. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 1.55.

  • [By Tyler Crowe]

    One of the attractive ways to invest in the oil and gas industry is in oil services companies. These picks-and-shovels businesses — or, in some cases, guns for hire to do a job — can generate great returns and can allow investors to target a specific trend in the industry like shale drilling or offshore development. When it comes to oil services giant Baker Hughes, a GE Company (NYSE:BHGE) and specialist Core Laboratories (NYSE:CLB), chances are you’re betting on the same trend in the industry even though the businesses themselves are so different.

Hot Undervalued Stocks To Watch Right Now: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

  • [By Joseph Griffin]

    Headlines about ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) have been trending somewhat negative recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by reviewing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. ANI Pharmaceuticals Inc Common Stock earned a media sentiment score of -0.08 on Accern’s scale. Accern also assigned news coverage about the specialty pharmaceutical company an impact score of 48.3270217581665 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Max Byerly]

    Mallinckrodt (NYSE: MNK) and ANI Pharmaceuticals Inc Common Stock (NASDAQ:ANIP) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability.

Hot Undervalued Stocks To Watch Right Now: NextEra Energy Partners, LP(NEP)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Nextera Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Jason Hall]

    It might be surprising to learn that there are a handful of solid dividend stocks in the renewables space: A segment more readily known for high-growth (or just high-risk) solar stocks is also where you can find some of the best dividend stocks out there. Three that look particularly compelling today are Pattern Energy Group (NASDAQ:PEGI), TerraForm Power (NASDAQ:TERP), and NextEra Energy Partners (NYSE:NEP).

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Nextera Energy Partners (NEP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Maxx Chatsko]

    For the most part, a nuclear or coal-fired power plant in Maine will generate the same amount of electricity as an identical power plant of the same type in Texas. But the energy output of several identical wind or solar farms can vary quite a bit between locations, because they rely on their environment for “fuel”. It’s a huge consideration when weighing the portfolios of renewable energy asset companies such as Pattern Energy Group (NASDAQ:PEGI) and NextEra Energy Partners (NYSE:NEP).

  • [By Jon C. Ogg]

    While this call does not automatically generate a $100 billion market value in the next 12 months, it would put NextEra Energy within striking distance of being worth that much. The firm sees new growth opportunities at the non-regulated NextEra Energy Resources business and at the limited partnership, NextEra Energy Partners L.P. (NYSE: NEP), as contributing to its earnings growth and supporting its dividend.

Hot Undervalued Stocks To Watch Right Now: Six Flags Entertainment Corporation New(SIX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Private Advisor Group LLC trimmed its position in shares of Six Flags Entertainment Corp (NYSE:SIX) by 5.9% during the second quarter, Holdings Channel reports. The fund owned 14,836 shares of the company’s stock after selling 930 shares during the quarter. Private Advisor Group LLC’s holdings in Six Flags Entertainment were worth $1,040,000 as of its most recent SEC filing.

  • [By Shane Hupp]

    Integrity Gaming (OTCMKTS: IGAMF) and Six Flags (NYSE:SIX) are both consumer discretionary companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, analyst recommendations, earnings, risk and institutional ownership.

  • [By Max Byerly]

    Mason Street Advisors LLC grew its position in shares of Six Flags (NYSE:SIX) by 2.9% during the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 39,495 shares of the company’s stock after purchasing an additional 1,106 shares during the quarter. Mason Street Advisors LLC’s holdings in Six Flags were worth $2,459,000 as of its most recent filing with the SEC.

  • [By ]

    For his “Executive Decision” segment, Cramer sat down with Jim Reid-Anderson, chairman, president and CEO of Six Flags (SIX) , the theme park operator that just posted a 74-cents-a-share loss, compared to estimates for a loss of 79 cents. Shares rallied 5.6% on the news.

Best Safest Stocks To Watch For 2019

We have been fans of DNB (OTCPK:DNHBY) (OTCPK:DNBHF) for quite a long time now. It is the largest financial services group in Norway, and, more importantly, one of the safest banks in the world. A little less than a year ago, we said that DNB was offering a ‘once-in-a-lifetime’ buying opportunity. Our high-conviction contrarian call was based on the fact that DNB was trading at a very undemanding valuation, despite having a double-digit RoE, strong capital ratios and a 6% dividend yield. We also argued that market fears over the banks asset quality issues were overdone as DNB has a prudent risk management approach. Since that, DNB’s shares have rallied by 55%. And that does not include the stock’s generous dividends.

Best Safest Stocks To Watch For 2019: Orbital ATK, Inc.(OA)

Advisors’ Opinion:

  • [By Lisa Levin]

    Defense giant Northrop Grumman Corporation (NYSE: NOC) confirmed Monday it will buy Orbital ATK Inc (NYSE: OA), the maker of the Pegasus rocket and a vast array of other aerospace and defense systems, in a $9.2 billion deal.

  • [By Rich Smith]

    On one particularly big news day, April 28, the DSCA announced that it has notified Congress of no fewer than seven separate pending arms sales that it plans to push through. These deals are aiming to sell:

    110 radar-seeking air-to-ground “HARM” missiles to Australia, generating sales of $137.6 million for prime contractors Orbital ATK (NYSE:OA) and Raytheon (NYSE:RTN). Four P-8A Poseidonsubmarine-hunting jet aircraft to New Zealand — a $1.46 billion payday for Boeing (NYSE:BA). 13 76 mm cannonfor installation aboard Israeli Navy SA’AR 4.5 and SA’AR 6 Missile Patrol Boats at a purchase price of $440 million. (Italian firm Leonardo S.p.a.’s DRS North America subsidiary will be the contractor on that one.) Nine Bell 429light utility helicopters to Slovakia, yielding sales of $150 million for Textron (NYSE:TXT). And five CH-47D Chinookhelicopters, sold out of U.S. government surplus to Greece for $80 million.

    Also included in the DSCA’s list of pending contracts are two directed toward the NATO Support and Procurement Agency, specifically:

  • [By Jim Robertson]

    Last Monday, U.S. defense contractor Northrop Grumman Corporation (NYSE: NOC) announced it would buy Orbital ATK Inc (NYSE: OA), a direct Aerojet Rocketdyne competitor,for about $7.8 billion (a 22% premium to Orbital’s Friday close) in a deal thatwill give it greater access to lucrative government contracts and expand its arsenal of missile defense systems and space rockets. While Northrop already has a significant presence in payloads, it has not had launcher capability, an area that Orbital brings for both space and missile defense. Orbital also has contracts with NASA and the U.S. Army. The all-cash transaction is the biggest in the defense sector in two years and comes ahead of planned upgrades of U.S. ballistic systems (as the saber rattling by North Korea continues), which are expected to drive demand for missiles.

  • [By Rich Smith]

    Now consider that as of the last report, Americans owned 265 million guns — but fewer than 1 million silencers. That’s a huge market that American Outdoor Brands and Sturm, Ruger would love to sell into. Easing restrictions on silencer sales could have follow-on effects, too. Granting easier access to suppressors could reduce noise complaints at open-air shooting ranges, making it easier for such businesses to open, which would attract more customers, resulting in more ammunition being used, resulting in more ammunition being sold, resulting in more sales (and profits) for ammo makers such as Olin Corp (NYSE:OLN), Vista Outdoor (NYSE:VSTO), and Orbital ATK (NYSE:OA).

  • [By Rich Smith]

    Orbital ATK (NYSE:OA) occupies a charmed space in the U.S. market for putting satellites in, er, space.

    At one end of the space launch continuum, you have United Launch Alliance, whose Delta IV Heavy launch vehicle, developed by Boeing (NYSE:BA), can put a payload massing in excess of 28 tonsinto orbit in a single launch — at a cost of $350 million.At the other end, new space start-ups like Vector Space are promising to launch a new generation of small satellites into low-earth orbit for prices as little as $2 million a shot. But what about the middle?

  • [By Rich Smith]

    Much of this was based on educated guesswork, however, as we extrapolated what we knew about the finances at SpaceX rivalsBoeing(NYSE:BA),Lockheed Martin(NYSE:LMT),Orbital ATK(NYSE:OA), andAirbus(NASDAQOTH:EADSY), and applied it to what wethoughtthat might mean for SpaceX’s own finances. It would have been a whole lot easier to just take a good hard look at SpaceX’s own financial documents, and get the answers straight from the source.

Best Safest Stocks To Watch For 2019: ANI Pharmaceuticals, Inc.(ANIP)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Canaccord Genuity set a $82.00 target price on ANI Pharmaceuticals (NASDAQ:ANIP) in a research report released on Tuesday morning. The firm currently has a buy rating on the specialty pharmaceutical company’s stock.

Best Safest Stocks To Watch For 2019: Monsanto Company(MON)

Advisors’ Opinion:

  • [By ]

    Bayer AG (BAYRY) also rose 4.13% to 97.29 on reports that its mega-merger with Monsanto Co. (MON) would likely be approved by the Department of Justice. The Wall Street Journal reported that the companies have agreed additional asset sales.

  • [By Maxx Chatsko]

    BeforeBayer(NASDAQOTH: BAYRY)arrived onto the scene, I viewedMonsanto(NYSE: MON)as an intriguing growth stock. It has a rich history of delivering value to shareholders and continues to hold a dominant technological edge over key competitors in crop protection products, seeds, and traits. While little has changed its promising pipeline and portfolio, the pending acquisition throws a wrench in anyone’s plans to start or add to a position. Uncertainty stemming from the merger provides several terrible reasons to buy Monsanto at this time.

  • [By Chris Lange]

    Monsanto Co. (NYSE: MON) is expected to share its most recent quarterly numbers first thing Thursday. Analysts are looking for $0.42 in earnings per share (EPS) and $2.77 billion in revenue. Shares were last seen at $116.78 apiece, in a 52-week range of $104.77 to $122.80. The consensus price target is $125.18.

  • [By Shanthi Rexaline]

    Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers

    Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.

    Agri-Finance Companies

  • [By Logan Wallace]

    Global X Management Co. LLC trimmed its stake in shares of Monsanto (NYSE:MON) by 6.8% during the first quarter, HoldingsChannel.com reports. The fund owned 11,141 shares of the basic materials company’s stock after selling 818 shares during the period. Global X Management Co. LLC’s holdings in Monsanto were worth $1,300,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Monsanto (NYSE:MON) was downgraded by equities research analysts at Argus from a “buy” rating to a “sell” rating in a research note issued to investors on Monday, The Fly reports.

Best Safest Stocks To Watch For 2019: MCBC Holdings, Inc.(MCFT)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    The Trade Desk, Inc. (NASDAQ: TTD) jumped 36.2 percent to $71.82 after the company reported upbeat results for its first quarter. The company also issued strong second-quarter and FY18 sales guidance.
    WideOpenWest, Inc. (NYSE: WOW) jumped 30.4 percent to $8.80 after the company reported Q1 results.
    MoSys, Inc. (NASDAQ: MOSY) shares surged 28.6 percent to $1.9541 after the company reported better-than-expected Q1 results and issued strong Q2 forecast.
    Boxlight Corporation (NASDAQ: BOXL) gained 24 percent to $6.39.
    Akcea Therapeutics, Inc. (NASDAQ: AKCA) shares gained 19.1 percent to $24.60. Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals Inc (NASDAQ: IONS) announced that the Endocrinologic and Metabolic Drugs Advisory Committee, which met to discuss the safety and efficacy of subcutaneously injected volanesoren solution for patients with familial chylomicronemia syndrome, voted 12-8 to support its approval.
    Net 1 UEPS Technologies, Inc. (NASDAQ: UEPS) shares rose 17 percent to $10.31 after reporting Q3 results.
    ArcBest Corporation (NASDAQ: ARCB) gained 16.8 percent to $43.1457 after reporting upbeat quarterly earnings.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 16.2 percent to $8.60. Amtech posted Q2 earnings of $0.19 per share on sales of $32.783 million.
    Identiv, Inc (NASDAQ: INVE) surged 14.4 percent to $3.8450 following Q1 results.
    Omeros Corporation (NASDAQ: OMER) shares rose 14.3 percent to $18.43 following Q1 results.
    VivoPower International PLC (NASDAQ: VVPR) gained 11.5 percent to $2.71.
    Intersections Inc. (NASDAQ: INTX) gained 11.4 percent to $2.55 after reporting Q1 results.
    Noodles & Company (NASDAQ: NDLS) shares rose 10.9 percent to $8.65 following Q1 results.
    Voyager Therapeutics, Inc. (NASDAQ: VYGR) climbed 10.6 percent to $18.54 following Q1 results.
    Blink Charging Co. (NASDAQ: BLNK) rose 10.4 percent to $5.739.
    Immersion Corporation (NASDAQ: IMMR) gained 9.6 percent to $12.69

Best Safest Stocks To Watch For 2019: Starbucks Corporation(SBUX)

Advisors’ Opinion:

  • [By Seth McNew]

    Some of what Chipotle is doing comes from Starbucks’ (NASDAQ:SBUX) playbook. The coffee company was a trailblazer in creating a digital and mobile strategy that has truly transformed the customer experience and added to Starbucks’ bottom line. Its app, which features a mobile wallet-style system of stored preferences and the ability to order ahead to pick up your drink without waiting in line, now has more than 13 million active users, and the company has pointed to its digital growth many times as a boost to its comparable-store sales and margin growth. Mobile payments now make up one-quarter of all Starbucks transactions.

  • [By Logan Wallace]

    Cypress Wealth Services LLC trimmed its holdings in shares of Starbucks (NASDAQ:SBUX) by 7.7% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 18,248 shares of the coffee company’s stock after selling 1,533 shares during the quarter. Cypress Wealth Services LLC’s holdings in Starbucks were worth $1,056,000 at the end of the most recent quarter.

  • [By Motley Fool Staff]

    Barker: Yeah, it’s a little jarring, “McDonald’s restaurants,” because I guess the image I have, in my head at least, of a restaurant is a little bit more of a sit-down experience than the counter experience. This is not a shot at McDonald’s, although we could go in that direction if you have a good line or something, but I feel the same way about Starbucks(NASDAQ:SBUX) also included in the restaurant category.

  • [By Lisa Levin] Gainers
    Gramercy Property Trust (NYSE: GPT) rose 13.4 percent to $27.01 in pre-market trading after the company agreed to be acquired by Blackstone Group L.P. (NYSE: BX) for $27.50 per share.
    Warrior Met Coal, Inc. (NYSE: HCC) rose 9.1 percent to $30 in pre-market trading after climbing 5.61 percent on Friday.
    Check-Cap Ltd. (NASDAQ: CHEK) rose 6.2 percent to $4.83 in pre-market trading after falling 48.35 percent on Friday.
    Ceragon Networks Ltd. (NASDAQ: CRNT) rose 6 percent to $2.85 in pre-market trading after climbing 1.89 percent on Friday.
    Ctrip.com International, Ltd. (NASDAQ: CTRP) rose 4.8 percent to $43.15 in pre-market trading.
    G1 Therapeutics, Inc. (NASDAQ: GTHX) rose 3.2 percent to $44.00 in pre-market trading after climbing 6.92 percent on Friday.
    Synchrony Financial (NYSE: SYF) rose 3.2 percent to $33.68 in pre-market trading after gaining 2.03 percent on Friday.
    Starbucks Corporation (NASDAQ: SBUX) rose 3.1 percent to $59.45 in pre-market trading. Nestle announced plans to acquire rights to market, sell and distribute Starbucks Brands.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Chris Lange]

    Starbucks Corp. (NASDAQ: SBUX) is expected to report its most recent quarterly results on Thursday as well. The consensus estimates call for $0.55 in EPS and $5.75 billion in revenue. Shares closed trading at $57.98 on Friday, in a 52-week range of $50.84 to $64.87. The consensus price target is $66.52.